Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 6,783 | 3,820 | 3,016 | 3,698 | 3,860 |
| Cost of Goods | 2,846 | 1,710 | 1,507 | 1,601 | 1,526 |
| Gross Profit | 3,937 | 2,110 | 1,509 | 2,097 | 2,334 |
| Operating Expenses | 9,517 | 7,685 | 5,934 | 5,503 | 5,505 |
| Operating Income | -4,734 | -4,865 | -3,918 | -2,805 | -2,645 |
| Other Income | -666 | -148 | 54 | -22 | 29 |
| Pre-tax Income | -5,400 | -5,013 | -3,864 | -2,827 | -2,616 |
| Net Income Continuous | -5,400 | -5,013 | -3,864 | -2,827 | -2,616 |
| Net Income | $-5,400 | $-5,013 | $-3,864 | $-2,827 | $-2,616 |
| EPS Basic Total Ops | -0.49 | -0.55 | -0.45 | 0.41 | -0.40 |
| EPS Basic Continuous Ops | -0.49 | -0.55 | -0.45 | 0.40 | -0.40 |
| EPS Diluted Total Ops | -0.49 | -0.55 | -0.45 | 0.41 | -0.40 |
| EPS Diluted Continuous Ops | -0.49 | -0.55 | -0.45 | 0.40 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.55 | -0.45 | -0.28 | -0.40 |
| EBITDA(a) | $-4,350 | $-4,559 | $-3,741 | $-2,661 | $-2,499 |